TrialJournal of clinical pharmacology2022

Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study.

Peijuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.